Australia - English - Department of Health (Therapeutic Goods Administration)

csl behring australia pty ltd - water for injections, quantity: 40 ml - injection, solution - excipient ingredients: - treatment and perioperative prophylaxis of bleedings in acquired deficiency of the prothrombin complex coagulation factors, such as deficiency caused by treatment with vitamin k antagonists, or in case of overdose of vitamin k antagonists, when rapid correction of the deficiency is required.

Australia - English - Department of Health (Therapeutic Goods Administration)

csl behring australia pty ltd - water for injections, quantity: 20 ml - injection, solution - excipient ingredients: - treatment and perioperative prophylaxis of bleedings in acquired deficiency of the prothrombin complex coagulation factors, such as deficiency caused by treatment with vitamin k antagonists, or in case of overdose of vitamin k antagonists, when rapid correction of the deficiency is required.

Canada - English - Health Canada

mediherb inc. - tobacco - tablet - 8x - tobacco 8x - homeopathic products

Bangladesh - English - DGDA (Directorate General of Drug Administration)

edruc ltd. - nicotinamide + pyridoxine hydrochloride + riboflavin + vitamin b1 - tablet - 20 mg + 2 mg + 2 mg + 5 mg

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

zontron pharmaceuticals sdn. bhd. - calcium pantothenate; thiamine mononitrate; nicotinamide; cyanocobalamin; pyridoxine hcl/vitamin b6; riboflavine -

Israel - English - Ministry of Health

csl behring ltd., israel - coagulation factor ii (human); coagulation factor ix (human- rfixfc); coagulation factor vii (human); coagulation factor x (human); protein c; protein s antigen - powder and solvent for solution for injection - coagulation factor ii (human) 200 - 480 iu; coagulation factor vii (human) 100 - 250 iu; coagulation factor ix (human- rfixfc) 200 - 310 iu; coagulation factor x (human) 220 - 600 iu; protein c 150 - 450 iu; protein s antigen 120 - 380 iu - coagulation factor ix, ii, vii and x in combination - coagulation factor ix, ii, vii and x in combination - treatment and perioperative prophylaxis of bleedings in acquired deficiency of the prothrombin complex coagulation factors, such as deficiency caused by treatment with vitamin k antagonists, or in case of overdose of vitamin k antagonists, when rapid correction of the deficiency is required.

Ireland - English - HPRA (Health Products Regulatory Authority)

csl behring gmbh - factor ii activity; factor vii activity; factor x activity; factor ix activity; protein c activity; protein s antigen - powder and solvent for solution for injection - 250 international unit(s) - blood coagulation factors; coagulation factor ix, ii, vii and x in combination

Ireland - English - HPRA (Health Products Regulatory Authority)

csl behring gmbh - factor ii activity; factor vii activity; factor x activity; factor ix activity; protein c activity; protein s antigen - powder and solvent for solution for injection - 500 international unit(s) - blood coagulation factors; coagulation factor ix, ii, vii and x in combination

Ireland - English - HPRA (Health Products Regulatory Authority)

csl behring gmbh - factor ii activity; factor vii activity; factor x activity; factor ix activity; protein c activity; protein s antigen - powder and solvent for solution for injection - 1000 international unit(s) - blood coagulation factors; coagulation factor ix, ii, vii and x in combination

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

csl behring uk ltd - protein s; factor ii; factor vii; factor ix; factor x; protein c - powder and solvent for solution for injection - 195unit ; 340unit ; 175unit ; 255unit ; 410unit ; 300unit